Alexza Pharmaceuticals (ALXA)

Add to Watchlists Create an Alert
4.575 +0.07  +1.44%   NASDAQ May 24, 5:00PM BATS Real time Currency in USD

Alexza Pharmaceuticals Cash and ST Investments:

11.71M for March 31, 2013
View Full Chart

Alexza Pharmaceuticals Cash and ST Investments Chart

    Alexza Pharmaceuticals Historical Cash and ST Investments Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 11.71M
    Dec. 31, 2012 17.72M
    Sept. 30, 2012 25.52M
    June 30, 2012 18.53M
    March 31, 2012 24.43M
    Dec. 31, 2011 16.90M
    Sept. 30, 2011 28.32M
    June 30, 2011 38.66M
    March 31, 2011 31.84M
    Dec. 31, 2010 41.45M
    Sept. 30, 2010 52.65M
    June 30, 2010 41.67M
    March 31, 2010 40.98M
    Dec. 31, 2009 19.92M
    Sept. 30, 2009 14.72M
       
    June 30, 2009 26.04M
    March 31, 2009 40.73M
    Dec. 31, 2008 58.87M
    Sept. 30, 2008 77.98M
    June 30, 2008 95.32M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro

    About Cash and Short Term Investments

    Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

    Cash and short term investments are considered very liquid assets. For instance, if a company needs immediate liquidity, cash and short term investments can be be quickly used. Cash and short term investments are frequently used in liquidity ratios.
    Learn More

    Get data for

    ALXA Cash and ST Investments Benchmarks

    Companies
    Teva Pharmaceutical Industries 1.394B
    Forest Laboratories
    POZEN 87.31M

    ALXA Cash and ST Investments Rankings

    Overall 59th percentile
    3253 of 8009
    Sector 44th percentile
    382 of 687 in Healthcare
    Industry 36th percentile
    44 of 69 in Drug Manufacturers - Specialty & Generic

    ALXA Cash and ST Investments Range, Past 5 Years

    Minimum 11.71M Mar 2013
    Maximum 95.31M Jun 2008
    Average 36.20M